Environmental Amsler test as a monitoring tool for retreatment with ranibizumab for neovascular age-related macular degeneration

This publication has 11 references indexed in Scilit:

• DISTORTION MAPS FROM PREFERENTIAL HYPERACUITY PERIMETRY ARE HELPFUL IN MONITORING FUNCTIONAL RESPONSE TO LUCENTIS THERAPY
  Retina, 2009
• Ranibizumab: The clinician's guide to commencing, continuing, and discontinuing treatment
  Eye, 2008
• Macular function surveillance revisited
  Optometry - Journal of the American Optometric Association, 2008
• Recent progress in macular function self‐assessment
  Ophthalmic and Physiological Optics, 2008
• Comparison of the original Amsler grid with the preferential hyperacuity perimeter for detecting choroidal neovascularization in age-related macular degeneration
  Arquivos Brasileiros de Oftalmologia, 2007
• An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration
  American Journal of Ophthalmology, 2007
• Visual Function in Patients With Choroidal Neovascularization Resulting From Age‐Related Macular Degeneration: The Importance of Looking Beyond Visual Acuity
  Optometry and Vision Science, 2006
• Role of the Completion Phenomenon in the Evaluation of Amsler Grid Results
  American Journal of Ophthalmology, 1995
• Validity and Interpretation of Amsler Grid Reports
  Archives of Ophthalmology (1950), 1993
• Earliest Symptoms Caused by Neovascular Membranes in the Macula
  Archives of Ophthalmology (1950), 1986